BACKGROUND: A number of single gene defects have been identified in patients with isolated or nonsyndromic congenital heart defects (CHDs). However, due to significant genetic heterogeneity, candidate gene approaches have had limited success in finding high-risk alleles in most cases. The purpose of this study was to use exome sequencing to identify high-risk gene variants in a family with highly penetrant pleiotropic CHD. METHODS AND RESULTS: DNA samples from 2 members of a family with diverse CHD were analyzed by exome sequencing. Variants were filtered to eliminate common variants and sequencing artifacts and then prioritized based on the predicted effect of the variant and on gene function. The remainder of the family was screened using polymerase chain reaction, high-resolution melting analysis, and DNA sequencing to evaluate variant segregation. After filtering, >2000 rare variants (including single nucleotide substitutions and indels) were shared by the 2 individuals. Of these, 46 were nonsynonymous, 3 were predicted to alter splicing, and 6 resulted in a frameshift. Prioritization reduced the number of variants potentially involved in CHD to 18. None of the variants completely segregated with CHD in the kindred. However, 1 variant, Myh6 Ala290Pro, was identified in all but 1 affected individual. This variant was previously identified in a patient with tricuspid atresia and large secundum atrial septal defect. CONCLUSIONS: It is likely that next-generation sequencing will become the method of choice for unraveling the complex genetics of CHD, but information gained by analysis of transmission through families will be crucial.
BACKGROUND: A number of single gene defects have been identified in patients with isolated or nonsyndromic congenital heart defects (CHDs). However, due to significant genetic heterogeneity, candidate gene approaches have had limited success in finding high-risk alleles in most cases. The purpose of this study was to use exome sequencing to identify high-risk gene variants in a family with highly penetrant pleiotropic CHD. METHODS AND RESULTS: DNA samples from 2 members of a family with diverse CHD were analyzed by exome sequencing. Variants were filtered to eliminate common variants and sequencing artifacts and then prioritized based on the predicted effect of the variant and on gene function. The remainder of the family was screened using polymerase chain reaction, high-resolution melting analysis, and DNA sequencing to evaluate variant segregation. After filtering, >2000 rare variants (including single nucleotide substitutions and indels) were shared by the 2 individuals. Of these, 46 were nonsynonymous, 3 were predicted to alter splicing, and 6 resulted in a frameshift. Prioritization reduced the number of variants potentially involved in CHD to 18. None of the variants completely segregated with CHD in the kindred. However, 1 variant, Myh6 Ala290Pro, was identified in all but 1 affected individual. This variant was previously identified in a patient with tricuspid atresia and large secundum atrial septal defect. CONCLUSIONS: It is likely that next-generation sequencing will become the method of choice for unraveling the complex genetics of CHD, but information gained by analysis of transmission through families will be crucial.
Authors: S T Sherry; M H Ward; M Kholodov; J Baker; L Phan; E M Smigielski; K Sirotkin Journal: Nucleic Acids Res Date: 2001-01-01 Impact factor: 16.971
Authors: Salah A Mohamed; Zouhair Aherrahrou; Henrike Liptau; Armin W Erasmi; Carolin Hagemann; Sandra Wrobel; Katja Borzym; Heribert Schunkert; Hans H Sievers; Jeanette Erdmann Journal: Biochem Biophys Res Commun Date: 2006-05-15 Impact factor: 3.575
Authors: Mark Yandell; Chad Huff; Hao Hu; Marc Singleton; Barry Moore; Jinchuan Xing; Lynn B Jorde; Martin G Reese Journal: Genome Res Date: 2011-06-23 Impact factor: 9.043
Authors: Yung-Hao Ching; Tushar K Ghosh; Steve J Cross; Elizabeth A Packham; Louise Honeyman; Siobhan Loughna; Thelma E Robinson; Andrew M Dearlove; Gloria Ribas; Andrew J Bonser; Neil R Thomas; Andrew J Scotter; Leo S D Caves; Graham P Tyrrell; Ruth A Newbury-Ecob; Arnold Munnich; Damien Bonnet; J David Brook Journal: Nat Genet Date: 2005-02-27 Impact factor: 38.330
Authors: Vidu Garg; Alecia N Muth; Joshua F Ransom; Marie K Schluterman; Robert Barnes; Isabelle N King; Paul D Grossfeld; Deepak Srivastava Journal: Nature Date: 2005-07-17 Impact factor: 49.962
Authors: J J Schott; D W Benson; C T Basson; W Pease; G M Silberbach; J P Moak; B J Maron; C E Seidman; J G Seidman Journal: Science Date: 1998-07-03 Impact factor: 47.728
Authors: Daniel M Webber; Stewart L MacLeod; Michael J Bamshad; Gary M Shaw; Richard H Finnell; Sanjay S Shete; John S Witte; Stephen W Erickson; Linda D Murphy; Charlotte Hobbs Journal: Birth Defects Res A Clin Mol Teratol Date: 2015-05-28
Authors: Deidre R Krupp; Karen L Soldano; Melanie E Garrett; Heidi Cope; Allison E Ashley-Koch; Simon G Gregory Journal: Birth Defects Res A Clin Mol Teratol Date: 2014-07-21
Authors: Stephanie LaHaye; Don Corsmeier; Madhumita Basu; Jessica L Bowman; Sara Fitzgerald-Butt; Gloria Zender; Kevin Bosse; Kim L McBride; Peter White; Vidu Garg Journal: Circ Cardiovasc Genet Date: 2016-07-14
Authors: Neil E Bowles; Chuanchau J Jou; Cammon B Arrington; Brett J Kennedy; Aubree Earl; Norisada Matsunami; Lindsay L Meyers; Susan P Etheridge; Elizabeth V Saarel; Steven B Bleyl; H Joseph Yost; Mark Yandell; Mark F Leppert; Martin Tristani-Firouzi; Peter J Gruber Journal: Am J Med Genet A Date: 2015-08-18 Impact factor: 2.802
Authors: Alan Fung; Cedric Manlhiot; Sapna Naik; Herschel Rosenberg; John Smythe; Jane Lougheed; Tapas Mondal; David Chitayat; Brian W McCrindle; Seema Mital Journal: J Am Heart Assoc Date: 2013-05-31 Impact factor: 5.501
Authors: Neil E Bowles; Cammon B Arrington; Keiichi Hirono; Tsuneyuki Nakamura; Long Ngo; Yin Shen Wee; Fukiko Ichida; John H Weis Journal: Mol Genet Genomic Med Date: 2014-05-14 Impact factor: 2.183